Table 6.
Year | Team | Source of stem cells | Results |
---|---|---|---|
2016 | Wang et al. [81] | Human WJMSCs | WJMSCs genes expression pattern is similar to ADMSCs, inflammatory stimulation can regulate genes expression |
2018 | Beeravolu et al. [82] | Induce human WJMSCs differentiating into CPCs | Cell structure change, glycosaminoglycan content and ECM↑ |
2019 | Qi et al. [83] | Human WJMSCs | Activate MAPK signaling pathway, promote B-cell lymphoma-2 expression and inhibit Bax expression, ECM↑and ECM degradation ↓, COL II and proteoglycan content↑, regulate mitosis and apoptosis |
2020 | Zhao et al. [84] | Human WJMSCs + human NP cells | Reverse the apoptotic ratio of NP cells, block Wnt/β-catenin pathway to inhibit Wnt-related genes expression |
2013 | Barreto et al. [85] | Rabbit NPSCs | NPSCs migrate along the fibers and cells in IVD |
2016 | Wang et al. [86] | BMSCs/NPSCs/AFSCs/CESCs | CESCs are stronger in osteogenesis and chondrogenesis than the other three |
2017 | Huang et al. [87] | NPSCs | Hypoxia can promote NPSCs proliferation related to HIF-1α signaling pathway, Simvastatin can promote NPSCs transfer into NP cells |
2018 | He et al. [88] | Human CESCs | Promote CEPs repair, promote NP cells proliferation |
2015 | Liu et al. [89] | Human IPSCs + pig NP cell ECM | NP cells secret regulatory factors, mediate the differentiation of IPSCs into NP cells |
2020 | Hu et al. [90] | GDF-5 transfected human IPSCs + rat NP cells | Chondrocyte markers genes expression↑ |
ADMSCs adipose mesenchymal stem cells, AFSCs annulus fibrosus stem cells, BMSCs bone marrow mesenchymal stem cells, CEPs cartilaginous endplates, CESCs cartilage endplate stem cells, COL II collagen type II, CPCs chondrogenic progenitor cells, ECM extracellular matrix, GDF growth differentiation factor, HIF hypoxia inducible factor, IPSCs induced pluripotent stem cells, IVD intervertebral disc, MAPK mitogen activated protein kinase, NP nucleus pulposus, NPSCs nucleus pulposus stem cells, WJMSCs Wharton's Jelly mesenchymal stem cells